Gil Blum
Stock Analyst at Needham
(3.68)
# 788
Out of 5,090 analysts
415
Total ratings
39.44%
Success rate
10.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLDB Solid Biosciences | Initiates: Buy | $16 | $5.93 | +170.04% | 1 | Dec 4, 2025 | |
| ABSI Absci | Maintains: Buy | $8 → $7 | $3.68 | +90.48% | 6 | Nov 13, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $81 → $80 | $58.85 | +35.94% | 26 | Nov 10, 2025 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $26 | $18.00 | +44.44% | 27 | Nov 4, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $9 → $6 | $1.09 | +450.46% | 8 | Nov 4, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $1.57 | +536.94% | 31 | Nov 3, 2025 | |
| CELC Celcuity | Reiterates: Buy | $70 | $106.01 | -33.97% | 21 | Oct 20, 2025 | |
| TSHA Taysha Gene Therapies | Reiterates: Buy | $10 | $5.06 | +97.63% | 31 | Oct 17, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $18 | $3.68 | +389.13% | 7 | Oct 17, 2025 | |
| RXRX Recursion Pharmaceuticals | Reiterates: Buy | $8 | $4.89 | +63.77% | 25 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.85 | +440.54% | 18 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | n/a | $22.81 | - | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $3.42 | - | 22 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $5 | $2.04 | +145.70% | 19 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $6.93 | +477.20% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $40.24 | +76.44% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $2.99 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $105 | $68.14 | +54.11% | 23 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $12.93 | +271.23% | 9 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.26 | +295.76% | 23 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Buy | $15 | $5.29 | +183.55% | 19 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.11 | - | 9 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $14 | $9.93 | +41.03% | 7 | Sep 18, 2025 |
Solid Biosciences
Dec 4, 2025
Initiates: Buy
Price Target: $16
Current: $5.93
Upside: +170.04%
Absci
Nov 13, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.68
Upside: +90.48%
CRISPR Therapeutics AG
Nov 10, 2025
Maintains: Buy
Price Target: $81 → $80
Current: $58.85
Upside: +35.94%
Nurix Therapeutics
Nov 4, 2025
Reiterates: Buy
Price Target: $26
Current: $18.00
Upside: +44.44%
TScan Therapeutics
Nov 4, 2025
Maintains: Buy
Price Target: $9 → $6
Current: $1.09
Upside: +450.46%
Autolus Therapeutics
Nov 3, 2025
Reiterates: Buy
Price Target: $10
Current: $1.57
Upside: +536.94%
Celcuity
Oct 20, 2025
Reiterates: Buy
Price Target: $70
Current: $106.01
Upside: -33.97%
Taysha Gene Therapies
Oct 17, 2025
Reiterates: Buy
Price Target: $10
Current: $5.06
Upside: +97.63%
Artiva Biotherapeutics
Oct 17, 2025
Reiterates: Buy
Price Target: $18
Current: $3.68
Upside: +389.13%
Recursion Pharmaceuticals
Sep 11, 2025
Reiterates: Buy
Price Target: $8
Current: $4.89
Upside: +63.77%
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $1.85
Upside: +440.54%
Jul 29, 2025
Reiterates: Underperform
Price Target: n/a
Current: $22.81
Upside: -
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $3.42
Upside: -
Jul 10, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $2.04
Upside: +145.70%
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $6.93
Upside: +477.20%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $40.24
Upside: +76.44%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $2.99
Upside: -
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $68.14
Upside: +54.11%
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $12.93
Upside: +271.23%
Apr 11, 2024
Reiterates: Buy
Price Target: $5
Current: $1.26
Upside: +295.76%
Nov 7, 2025
Suspends: Buy
Price Target: $15
Current: $5.29
Upside: +183.55%
Oct 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.11
Upside: -
Sep 18, 2025
Upgrades: Buy
Price Target: $14
Current: $9.93
Upside: +41.03%